# The Mother-Daughter Project: Merck-4

> **NCT07240220** · NA · NOT_YET_RECRUITING · sponsor: **Indiana University** · enrollment: 2500 (estimated)

## Conditions studied

- Cervical Dysplasia

## Interventions

- **BIOLOGICAL:** Gardisil-9
- **DIAGNOSTIC_TEST:** High Risk HPV DNA Testing
- **PROCEDURE:** Visual Inspection with acetic acid (VIA) and possible cervical biopsy

## Key facts

- **NCT ID:** NCT07240220
- **Lead sponsor:** Indiana University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-02-01
- **Primary completion:** 2028-08-01
- **Final completion:** 2028-08-01
- **Target enrollment:** 2500 (ESTIMATED)
- **Last updated:** 2026-01-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07240220

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07240220, "The Mother-Daughter Project: Merck-4". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT07240220. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*